Fiduciary Trust International of Pennsylvania’s Quest Diagnostics DGX Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,935	Closed	-$207K	–	359
2019 Q4	$207K	Sell	1,935 -40	-2%	-$4.17K	0.01%	315
2019 Q3	$211K	Buy	+1,975	New	+$203K	0.01%	369
2018 Q4	–	Sell	-1,910	Closed	-$206K	–	323
2018 Q3	$206K	Hold	1,910	–	–	0.01%	340
2018 Q2	$210K	Buy	+1,910	New	+$199K	0.01%	332
2017 Q3	–	Sell	-2,410	Closed	-$268K	–	342
2017 Q2	$268K	Hold	2,410	–	–	0.01%	358
2017 Q1	$237K	Hold	2,410	–	–	0.02%	288
2016 Q4	$221K	Hold	2,410	–	–	0.02%	285
2016 Q3	$204K	Buy	+2,410	New	+$202K	0.02%	297

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's DGX Position: Q1 2020 in Review

Fiduciary Trust International of Pennsylvania sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 1,935 shares — an estimated $207K sold.

Fiduciary Trust International of Pennsylvania first reported a position in DGX in Q3 2016 and held it in 8 quarters. The position peaked at $268K in Q2 2017. 715 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

Fiduciary Trust International of Pennsylvania reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
Fiduciary Trust International of Pennsylvania sold 1,935 Quest Diagnostics shares in Q1 2020, an estimated $207K.
Fiduciary Trust International of Pennsylvania first reported a position in Quest Diagnostics in Q3 2016 and held it in 8 quarters.
Fiduciary Trust International of Pennsylvania's Quest Diagnostics position peaked at $268K in Q2 2017.
715 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2020, filed 27 Apr 2020.